Effects of modafinil, caffeine and methylphenidate on functional brain activity and cognitive performance in healthy volunteers: a randomized, placebo-controlled, double-blind fMRI study.
Phase of Trial: Phase IV
Latest Information Update: 28 May 2019
Price : $35 *
At a glance
- Drugs Caffeine (Primary) ; Methylphenidate (Primary) ; Modafinil (Primary)
- Indications Apnoea; Attention-deficit hyperactivity disorder; Narcolepsy
- Focus Pharmacodynamics
- Acronyms MKM
- 16 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Mar 2014 New trial record